Back To: Home



June 6-7, 2013
European Lab Automation - Hamburg, Germany

June 12-15, 2013

More Events
Name:
Company:
Email:
 
 
 
Transfect with Confidence. Roche X-tremeGENE Transfection Reagents

Comment period reopened for advertising rule
March 2012
SHARING OPTIONS:

WASHINGTON—The U.S. Food and Drug Administration (FDA) has reopened the comment period for a proposed rule that would create standards for direct-to-consumer TV and radio advertisements regarding drug side effects. The rule, proposed in 2010, would require that the main point in said advertisements be “presented in a clear, conspicuous and neutral manner.” The reopened period is intended for the assessment of a document added to the docket, a “distraction study” to investigate factors that might influence viewers’ understanding of risks and side effects in TV advertising. The study examined the effects of superimposed text, emotional tone of images and consistency of images with risk information. According to the FDA’s findings, simultaneous audio and textual presentation of information improved understanding, but no support was found that understanding is influenced by the emotional tone of images.

Back

cISBIO

ATCC


nanoString

Singulex

European Lab Automation

ISSCR
CONTACT US
Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2013 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.